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Abstract
Background: The potential impact of HIV-1 on falciparum malaria has been difficult to determine
because of diagnostic problems and insufficient epidemiological data.
Methods: In a prospective, cross-sectional study, clinical and laboratory data was registered
consecutively for all adults admitted to a medical ward in the Central Hospital of Maputo,
Mozambique, during two months from 28th October 2006. Risk factors for fatal outcome were
analysed. The impact of HIV on the accuracy of malaria diagnosis was assessed, comparing
"Presumptive malaria", a diagnosis assigned by the ward clinicians based on fever and symptoms
suggestive of malaria in the absence of signs of other infections, and "Verified malaria", a malaria
diagnosis that was not rejected during retrospective review of all available data.
Results: Among 333 included patients, fifteen percent (51/333) had "presumptive malaria", ten
percent (28 of 285 tested persons) had positive malaria blood slides, while 69.1% (188/272) were
HIV positive. Seven percent (n = 23) had "verified malaria", after the diagnosis was rejected in
patients with neck stiffness or symptom duration longer than 2 weeks (n = 5) and persons with
negative (n = 19) or unknown malaria blood slide (n = 4). Clinical stage of HIV infection (CDC),
hypotension and hypoglycaemia was associated with fatal outcome. The "presumptive malaria"
diagnosis was rejected more frequently in HIV positive (20/31) than in HIV negative patients (2/10,
p = 0.023).
Conclusion: The study suggests that the fraction of febrile illness attributable to malaria is lower
in HIV positive adults. HIV testing should be considered early in evaluation of patients with
suspected malaria.
Background
The number of studies on prevalence and clinical manifes-
tations of HIV 1 and falciparum malaria in Mozambique
is limited, especially in adult inpatients. Mozambique is
one of the countries in sub-Saharan Africa with the high-
est incidences of co-infection with HIV and malaria, with
about 270 annual malaria cases per 1,000 inhabitants and
an estimated HIV prevalence in adults of 16.1% in 2005
[1]. More than a quarter of the population in Maputo city
may be HIV infected [2]. Nationally, approximately 3,500
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die due to malaria annually [3]. Mozambique has stable
malaria transmission with peak transmission from Octo-
ber – December to March-April [3], and Plasmodium falci-
parum accounts for 95% of the cases [4]. The quality of the
data on HIV and malaria has been questioned in Mozam-
bique and in several other developing countries [2,5-7].
There is controversy as to the degree of impact HIV has on
malaria infection. Increasing severity of HIV is associated
with increased risk of acquiring malaria infection, and of
severe disease and death from malaria in areas with unsta-
ble malaria transmission [8-14]. Available studies are lim-
ited by low sample sizes and have failed to demonstrate
any association between malaria case-fatality rates and
HIV seropositivity among hospitalized patients in areas
with stable malaria transmission [15]. Some postulate
that HIV alters the clinical presentation of malaria [14].
Other investigators report increased treatment failure of
antimalarials in HIV positive patients [16,17], whereas
others contradict this finding [9,18].
Febrile illness is a common complaint in HIV patients and
may be due to a multitude of other causes than malaria,
including viral, bacterial and other parasitic or opportun-
istic infections, many of which may have clinical features
indistinguishable from malaria [10,19]. Adverse effects of
antiretrovirals and other medicines, including the
immune reconstitution syndrome may also give rise to
febrile illness [1]. The fact that people in endemic areas
may have asymptomatic malaria parasitemia further com-
plicates the diagnosis of febrile illness in HIV infected
people [1,10,20].
The current study describes the prevalence and clinical
manifestations of co-infection with HIV and malaria in
hospitalized adult patients in Maputo and examines the
impact of HIV on malaria infection with fatal outcome as
primary end-point.
Methods
Setting
The Central Hospital of Maputo is a public tertiary teach-
ing hospital that serves Maputo's 1.1 million citizens and
also functions as national referral hospital for Mozam-
bique. Patients are admitted on rotation, according to
weekdays into the four medical wards.
Study population
From the 28th October to the 28th December 2006, a pro-
spective, cross-sectional study was carried out on all adult
patients consecutively admitted to the medical ward no. 1
in the Central Hospital of Maputo. On admission and
during daily ward rounds the ward medical doctors
recorded observations in the patient's medical record. For
patients with suspected infectious disease, a predefined
set of clinical data was collected, including the duration of
symptoms, the severity of the disease, the presence of clin-
ical criteria for severe sepsis and severe malaria according
to international definitions, clinical signs of HIV, the clin-
ical stage of HIV disease according to the CDC (US Cent-
ers for Disease Control) and the degree of consciousness
according to the Modified Glasgow Coma Scale. The
recorded data included sex, age, and admission diagnosis,
date of admission and discharge. All clinical information,
as well as laboratory and x-ray results, was available for
the researcher, who registered these into patient records
during daily visits. Each patient record was observed on
admission and followed up twice weekly, to observe alter-
ations in the condition of the patient or in the diagnosis
done. Most patients were also seen by the researcher
together with the ward doctor who was responsible for the
patient. Patients who were both admitted and discharged
or who died during the same weekend, sometimes had
limited observations and laboratory investigation per-
formed. The data was crosschecked with the nurses' regis-
tries of deaths and HIV positive patients and with the
ward statistic manager's registries of admissions, dis-
charges, diagnoses and deaths. The patient outcome was
dichotomized as either "discharged alive from the hospi-
tal" or "fatal outcome", meaning that the patient died dur-
ing the hospital stay. Case-fatality rates were calculated as
number of patients with "fatal outcome" divided by the
total number of patients included in the study. When
available, the results of HIV and malaria tests were
recorded. Diagnoses on admission and discharge were
registered. If there was a change in the clinical working
diagnosis, the change was usually made during the first
regular ward round after admission. All tests were per-
formed on request from the clinicians. The HIV tests were
usually requested during the first regular ward round.
Pregnancy tests were not done routinely. Patients under
16 years of age were excluded from the study.
Two different definitions of malaria were used, "presump-
tive malaria" and "verified malaria". "Presumptive
malaria" means that the clinicians in the ward have given
the patient a working diagnosis of malaria based on symp-
toms suggestive of malaria such as fever, headache, men-
tal confusion, vomiting and diarrhoea, difficulty in
breathing, general body ache or other influenza-like
symptoms, in the absence of symptoms or findings indi-
cating other infections. Neck stiffness and history dura-
tion of more than two weeks were considered more
consistent with other infections than malaria. The term
"verified malaria" is used for patients, who have both clin-
ical features of malaria ("presumptive malaria"), a posi-
tive malaria slide, and for whom the malaria diagnosis has
not been rejected due to symptoms more consistent with
other infections, such as neck stiffness or symptom dura-
tion of more than two weeks. Only patients with a docu-Malaria Journal 2008, 7:252 http://www.malariajournal.com/content/7/1/252
Page 3 of 8
(page number not for citation purposes)
mented positive HIV test were considered as HIV cases,
and not those with clinically suspected HIV. Opportunis-
tic infections were recorded when clinically suspected or
when verified by tests.
Laboratory methods
HIV tests were performed with both the Determine
(Abbot Japan co, Ltd) and Unigold (Trinity Biotech plc,
Bray, Ireland) tests. Malaria slides were prepared and eval-
uated as part of the hospital routine. Microscopy of Gram
and Ziehl-Neelsen stained slides and culture for Mycobac-
terium tuberculosis were performed according to standard
procedures in the hospital's microbiological laboratory.
Statistical methods
Statistical analysis was performed with the Stata software
(Stata Corps, College Station, TX). In the univariate anal-
ysis of risk factors for fatal outcome, odds ratios, 95% con-
fidence intervals and p-values were calculated. In the
multivariable analysis of risk factors for fatal outcome, all
explanatory variables with a univariate significance level
of p < 0.2 were included in the initial model. Automated
stepwise backwards logistic regression modelling was per-
formed, removing variables with p-values < 0.2 in order of
decreasing p-values. HIV infection was included both as a
dichotomized variable (infected or not infected) and as
the degree of immunosuppression recorded as an ordinal
variable with the values "0" for not infected and "1"
through "3" for those with HIV infection with CDC (US
Centers for Diseases Control) clinical stage from A
through C, respectively. The a priori important variables,
age (number of years) and sex were included in the model
to adjust for potential confounding, but removed from
the model on equal terms as other variables when p-val-
ues exceeded 0.2. For the purpose of analysis of risk fac-
tors for fatal outcome, an assumption was made for the
variables "neck stiffness", "diarrhoea", "cough" and
"hypotension" that a missing value equalled absence of
the particular feature. Likewise, for the tests of serum cre-
atinine, platelet counts and blood sugar, missing values
were grouped together with normal test results for the pur-
pose of risk factor analysis. Assessment of the association
between HIV status and malaria was performed by Fisher's
exact test. The association between HIV status and the risk
of receiving a wrong malaria diagnosis was evaluated by
Fisher's exact test, and confounding by age and sex was
evaluated by logistic regression. Risk of fatal outcome
among patients with verified and rejected final diagnosis
of malaria was evaluated by Fisher's exact test.
Ethical considerations
The data recorded were obtained as part of routine clinical
examination and routine blood tests. No interventions
were done and no additional testing was initialized on
behalf of the study. Patients were recorded anonymously,
without names or other traceable identification. To pre-
vent mixing of patients, admission dates and bed-num-
bers, which together were unique for each and every
patient, were recorded. The National Ethical Committee
at the Ministry of Health in Mozambique approved the
study and granted permission that the study could be per-
formed without asking for the consent from the patients.
Results
Characteristics of the study population
A total of 333 adult patients were included in the study,
and among these 272 patients (81,7%) were tested for
HIV, 285 (85.6%) were tested for malaria and 241
(72.4%) had both tests done. The median age was 38
years (range 16–92). The median age for HIV positive
patients, HIV negative patients and for patients with veri-
fied malaria was 33, 49 and 34 years, respectively. The
proportion of females was 50% in the total study popula-
tion, 51% in the HIV positive patients and 39% in the
patients with verified malaria.
Prevalence of HIV and malaria
Among those tested, sixty-nine percent (188/272) had a
positive HIV test. Fifteen percent (51/333) of the study
subjects were diagnosed with "presumptive malaria" on
clinical grounds. Malaria parasitemia was found in ten
percent (28/285) of those tested. After retrospective
review of all information available for the 28 patients with
positive malaria blood slide, the malaria diagnosis was
discarded for five patients who had neck stiffness or dura-
tion of symptoms over two weeks, considered clinical
signs more consistent with other infections than malaria,
the most common being meningoencephalitis and tuber-
culosis. Thus, in retrospect, seven percent (23/333) of the
total study population were given a final diagnosis of "ver-
ified malaria". Among the 23 patients with "verified
malaria", eleven were HIV positive. All five patients with
malaria parasitemia who had their malaria diagnosis
rejected were HIV positive. Ninety-two patients had nei-
ther a HIV test nor a malaria blood slide done.
Case-fatality rates
The in-hospital case-fatality rate was 15.3% (51/333) for
the total study population. Having a positive HIV test was
not associated with a significantly higher case-fatality rate.
However, trend analysis showed that the severity of HIV
disease was significantly associated with increasing case-
fatality rates (CDC stage A: 4.5% (1/22), stage B: 16.7%
(5/30) and stage C: 21.0%, (30/143), odds ratio 1.36
(1.04–1,78), p = 0.026). Neither a positive malaria test
nor increasing malaria parasitemia was significantly asso-
ciated with fatal outcome (table 1). Neither a diagnosis of
"presumptive malaria" nor "verified malaria" was associ-
ated with an increased risk of fatal outcome. Two died
among the five malaria parasitemic patients, who had theMalaria Journal 2008, 7:252 http://www.malariajournal.com/content/7/1/252
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Table 1: Risk factors for fatal outcome
Characteristic Case fatality rate (deaths/no 
at risk)*
Univariate analysis OR 
(95%CI)
p Multivariate analysis, 
adjusted OR (95%CI), P †
Overall 15.3% (51/333)
Age (no of years)‡ NA 0.98 (0.97–1.00) 0.071 Removed
(p = 0.433)
Sex: 0.682 Removed
(p = 0.257)
Female 14.5% (24/165) 1
Male 16.2% (27/167) 1.13 (0.62–2.06)
Malaria parasitemia 0.859
Negative 15.6% (40/257) 1
Positive 14.3% (4/28) 0.90 (0.30–2.75)
Malaria parasitemia
(graded 1–5)‡
NA 1.02 (0.75–1.40) 0.889
High parasitemia 0.261
<5% of erythrocytes 14.8% (40/270) 1
≥ 5% of erythrocytes 27.3% (3/11) 2.16 (0.55–8.52)
Initial diagnosis 0.936
Other than malaria 15.3% (43/282) 1
Presumptive malaria 15.7% (8/51) 1.03 (0.45 – 2.35)
Retrospective diagnosis 0.166 Removed
(p = 0.401)
Other than malaria 20.9% (39/187) 1
Verified malaria 8.7% (2/23) 0.36 (0.08 – 1.62)
HIV test result 0.103 Removed
(p = 0.290)
Negative 10.7% (9/84) 1
Positive 18.6% (35/188) 1.91 (0.87–4.19)
CDC HIV stage‡§ NA 1.36 (1.04–1.78) 0.026 1.87 (1.01–3.47)
p = 0.048
Anti retroviral therapy 0.953
Not on ART 15.4% (45/293) 1
On ART 15.0% (6/40) 0.97 (0.39–2.45)
Hypotension 0.057 4.02 (1.01–15.89)
p = 0.048
No hypotension reported 14.5% (46/318) 1
Blood pressure <90 mmHg 33.3% (5/15) 2.96 (0.97–9.04)
Neck stiffness 0.323
No neck stiffness reported 15.8% (50/317) 1
Stiff neck 6.3% (1/16) 0.36 (0.05–2.76)
Cough 0.757
No cough reported 14.9% (36/241) 1
Coughing 16.3% (15/92) 1.11 (0.58–2.14)
Diarrhoea 0.862
No diarrhoea reported 15.5% (43/278) 1
Diarrhoea present 14.5% (8/55) 0.93 (0.41–2.11)
Serum creatinine 0.907
< 175 μmol/L or not tested 15.2% (44/289) 1
≥ 175 μmol/L 15.9% (7/44) 1.05 (0.44–2.51)
Platelet counts 0.008 2.23 (0.94–5.33)
p = 0.070
≥ 100 × 109/L or not tested 13.1% (37/283) 1
<100 × 109/L 28.0% (14/50) 2.59 (1.27–4.5.25)
Blood-glucose <0.001 13.57 (2.69–68.45)
p = 0.002
≥ 2.2 mmol/L or not tested 14.2% (46/324) 1
<2.2 mmol/L 55.6% (5/9) 7.55 (1.96–29.18)
CFR case-fatality rate, OR odds ratio, 95%CI 95% confidence interval, NA not applicable, CDC Centers for Disease Control, MPS = malaria 
parasite slide. * The number of observations in the CFR column varies because some patients' test results were not known. † 189 observations in 
final model ‡The Odds Ratio estimates for quantitative/ordinal variables are approximations to the odds ratio for a one unit increase. § 0 = negative, 
1 = CDC stage A, 2 = CDC stage B, 3 = CDC stage C.Malaria Journal 2008, 7:252 http://www.malariajournal.com/content/7/1/252
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malaria diagnosis rejected because clinical features were
more consistent with other diagnoses. However, there was
no statistically significant difference in the case-fatality
rates between patients with "verified malaria" (8.7%, 2/
23) and those with a retrospectively rejected malaria diag-
nosis (21.4%, 6/28, OR: 2.86 (95%CI 0.52–15.81) p =
0.227). A total of 92 patients did not have known test
results for HIV (n = 44), malaria (n = 31) or both HIV and
malaria (n = 17). There was no statistically significant
case-fatality rate between the 92 patients with missing
data for HIV and/or malaria (13.0% 12/92) and the 241
patients who had known HIV and malaria test results
(16.2% 39/241, OR: 1.29 (95%CI: 0.64–2.59) p = 0.478).
Increasing age was not associated with increased risk of
fatal outcome (Table 1).
Clinical manifestations
Although the most serious cases were transferred to the
intensive care unit, there was a high frequency of features
indicating severe illness in the study population. In the
comparison of symptoms, findings and laboratory results
of patients with final "verified malaria" diagnosis and
those with a final rejected malaria diagnosis, headache
was the only feature significantly associated with a final
diagnosis of "verified malaria" (34.8%, 8/23) as com-
pared to those with a final "rejected malaria" diagnosis
(3.6%, 1/28, OR: 14.4 (95%CI: 1.59–661.85) p = 0.004).
There was no significant difference in symptoms, clinical
findings and laboratory results between the HIV positive
and the HIV negative malaria patients (Table 2).
Table 2: The clinical manifestations of patients with presumptive malaria according to HIV status
Verified malaria Rejected malaria diagnosis All
HIV+ HIV- Total* HIV+ HIV- Total*
Total, n 12 8 23 20 2 28 51
Median age, years (n) 30 (11) 39 (8) 34 (23) 32 (20) 52 (2) 32 (28) 34 (51)
Female sex, n (%) 5 (42) 4 (50) 9 (39) 10 (50) 0 12 (43) 21 (41)
Median symptom duration, days (n) 7 (8) 3 (7) 7 (17) 7 (1)
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Vomiting 5 (42) 7 (88) 12 (52) 12 (60) 0 (0) 13 (46) 25 (49)
Diarrhoea 5 (42) 0 (0) 5 (22) 5 (25) 0 (0) 7 (25) 12 (24)
Headache † 3 (25) 4 (50) 8 (35) 0 (0) 1 (50) 1 (4) 9 (18)
Arthralgia 1 (8) 3 (38) 5 (22) 0 (0) 0 (0) 0 (0) 5 (10)
Dyspnoea 0 (0) 0 (0) 0 (0) 0 (0) 1 (50) 1 (4) 1 (2)
Loss of weight 1 (8) 0 (0) 0 (0) 5 (25) 0 (0) 5 (18) 6 (12)
Abdominal pain 1 (8) 1 (13) 2 (9) 0 (0) 0 (0) 0 (0) 2 (4)
Cough 1 (8) 0 (0) 2 (9) 8 (40) 0 (0) 8 (18) 7 (14)
Convulsions 0 (0) 0 (0) 0 (0) 2 (10) 1 (50) 4 (14) 4 (8)
Fever>4 weeks 0 (0) 0 (0) 0 (0) 2 (10) 0 (0) 2 (7) 2 (4)
Temperature>38.5°C 7 (58) 6 (75) 13 (57) 10 (50) 2 15 (54) 28 (55)
BP < 90 mmHg 0 (0) 0 (0) 1 (4) 4 (20) 1 (50) 6 (21) 7 (14)
Heart rate >100/min 3 (25) 1 (13) 5 (22) 10 (50) 0 (0) 10 (36) 15 (29)
Respiratory rate >20/min 4 (33) 0 (0) 5 (22) 8 (40) 1 (50) 9 (32) 14 (27)
Jaundice 2 (17) 1 (13) 3 (13) 2 (10) 0 (0) 2 (7) 5 (10)
Mental confusion 4 (33) 1 (13) 5 (22) 4 (20) 1 (50) 8 (29) 13 (25)
Cachexia 1 (8) 0 (0) 1 (4) 2 (10) 0 (0) 2 (7) 3 (6)
Neck stiffness 0 (0) 0 (0) 0 (0) 7 (35) 0 (0) 7 (25) 7 (14)
Hepatomegaly 0 (0) 0 (0) 0 (0) 1 (5) 0 (0) 1 (4) 1 (2)
Splenomegaly 0 (0) 0 (0) 0 (0) 1 (5) 0 (0) 1 (4) 1 (2)
WBC<4 or >12 × 109/L 3 (25) 1 (13) 5 (22) 7 (35) 1 (50) 9 (32) 14 (27)
Platelets<100 × 109/L 6 (50) 5 (63) 13 (57) 6 (30) 1 (50) 8 (29) 21 (41)
Creatinine>115 μmol/L 6 (50) 2 (25) 9 (39) 11 (55) 1 (50) 13 (46) 22 (43)
Blood glucose<2.2 mmol/L 0 (0) 0 (0) 0 (0) 2 (10) 1 (50) 3 (11) 3 (6)
HIV Stage A 0 (0) NA 0 (0) 0 (0) NA 0 (0) 0 (0)
HIV Stage B 2 (17) NA 2 (9) 1 (5) NA 1 (4) 3 (6)
HIV Stage C 7 (58) NA 7 (30) 11 (55) NA 11 (39) 18 (35)
MPS positive 12 (100) 8 (100) 23 (100) 5 (25) 0 (0) 5 (18) 28 (55)
Fatal outcome 1 (8) 1 (13) 2 (7) 4 (20) 0 (0) 5 (18) 7 (14)
BP systolic arterial blood pressure, WBC white blood cells. *Some of the totals don't add up, as some patients with unknown HIV result were 
included in the total, but not in the rest of the table. † Headache was significantly associated with a "verified malaria" diagnosis (p = 0.007)Malaria Journal 2008, 7:252 http://www.malariajournal.com/content/7/1/252
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HIV-malaria interaction
The proportion of patients with malaria parasitemia was
not significantly different between HIV positive (9.8%,
16/164) and HIV negative (10.4%, 8/77, OR: 0.93
(95%CI: 0.36–2.64) p = 0.878). In patients with docu-
mented malaria parasitemia, the degree of parasitemia
(graded from 1 to 5) was not significantly different
between HIV-positive (mean 2.8, 95%CI: 1.9–3.7) and
HIV-negative patients (mean: 3.5, 2.2–4.8, p = 0.170). In
five patients with documented malaria parasitemia, the
malaria diagnosis was rejected because other more plausi-
ble causes of the symptoms were found, and all of these
five were HIV positive. Still, the difference in this assumed
coincidental, not clinically relevant malaria parasitemia
was not statistically significant between HIV positive
(31.3%, 5/16) and HIV negative patients (0%, 0/8, p =
0.130). Upon retrospective analysis of the data, the
malaria diagnosis was rejected in more than half (n = 28)
of the 51 patients, who were given a working diagnosis of
"presumptive malaria" while in the ward. The malaria
diagnosis was rejected significantly more frequently in
HIV positive (64.5%, 20/31) than in HIV negative
patients (20%, 2/10, OR: 7.27 (95%CI: 1.31–40.42) p =
0.023). The malaria diagnosis was also rejected in 6 of 10
patients with unknown HIV status. As shown in Table 3,
HIV remained a risk factor for having a rejected malaria
diagnosis, even after adjusting for sex and age. There was
a borderline, but not statistically significant association
between increasing severity of immunosuppression and a
rejected malaria diagnosis (OR: 1.69, 95%CI: 0.99–2.89,
p = 0.54).
The case-fatality rate for patients with a rejected malaria
diagnosis was 21.4% (6/28) and for those with a verified
malaria diagnosis it was 8.7% (2/23), however, this differ-
ence was not statistically significant (OR: 2.86 (95%CI:
0.50–16.51), p = 0.269). Among patients with a diagnosis
of "verified malaria" there was no significant difference in
case-fatality rates among those who were HIV-positive
(9.1%, 1/11) and HIV-negative (12.5%, 1/8, OR: 0.70
(95%CI: 0.03–14.35) p = 1.0). Among HIV-positive
patients, only one person with verified malaria died (9%,
1/11), while four persons with rejected malaria diagnosis
(20%, 4/20) died, but this difference was not statistically
different (OR: 2.50 (95%CI: 0.23–27.34) p = 0.631).
Discussion
This study is one of a few reports addressing the issue of
malaria and HIV co-infection in Mozambique. In the
study, risk factors for fatal outcome were hypoglycaemia,
hypotension and severity of immunosuppression. Malaria
parasitemia and degree of parasitemia was not signifi-
cantly associated with fatal outcome. Upon retrospective
review of all available data, the malaria diagnosis was
rejected in more than half of the patients who initially had
received a working diagnosis of "presumptive malaria"
while in the ward. HIV positive patients were significantly
more likely to have their malaria diagnosis rejected than
HIV negative ones. Thus, the fraction of febrile illness
attributable to malaria in this study is less in HIV positive
than in HIV negative persons. The finding probably
reflects that HIV positive patients are prone to a number
of additional opportunistic infections and febrile illnesses
which may be difficult to distinguish clinically from
malaria, and thus, they run a greater risk of being misdi-
agnosed as having malaria. Other investigators have
raised concern regarding the reliability of malaria diagno-
sis in HIV patients [10,19,20]. Our study demonstrates a
statistically significant association between HIV status and
a risk of receiving an incorrect malaria diagnosis. The find-
ings raise concern that current practice may lead to over-
use of antimalarials and may leave a number of HIV
patients with opportunistic infections undiagnosed and
untreated. However, as the study population is small, fur-
ther studies should be performed to clarify this issue.
The difficulties in diagnosing malaria in HIV positive indi-
viduals are, at least partly, due to the fact that a number of
opportunistic and other infections in HIV patients may
mimic malaria. Even in HIV negative patients, malaria can
be clinically indistinguishable from other infections such
as viral infections or septicaemia [21,22]. The fact that a
proportion of people in endemic areas have asympto-
matic malaria parasitemia increases the diagnostic chal-
lenges [23,24]. Adverse effects of antiretrovirals and
immune reconstitution syndrome further complicate the
diagnostic process [1].
Clinicians in low-resource settings often face diagnostic
challenges due to a multitude of factors, including high
workload, poor facilities, unavailability and underuse of
equipment and laboratory tests and lack of access to up-
dated scientific literature and continued post-graduate
education programs [5,25-27]. The findings of this study
emphasize that the diagnosis of malaria is less straight-
forward in HIV patients than in HIV negative ones, and
that it is important to consider differential diagnoses, par-
ticularly opportunistic infections, in febrile HIV infected
persons living in malaria endemic areas. In this study,
meningoencephalitis and tuberculosis were the most
common diagnoses that were mistaken for malaria.
Table 3: Multivariate analysis of risk factors for receiving an 
incorrect diagnosis of malaria (number of observations = 40)
Characteristic Adjusted OR 95%CI p
Male sex 1.03 0.26 – 4.10 0.969
Age * 1.01 0.96 – 1.07 0.626
HIV infection 9.29 1.45 – 59.62 0.019
OR odds ratio, 95%CI 95% confidence interval. *Age is included as a 
continuous variable with number of years.Malaria Journal 2008, 7:252 http://www.malariajournal.com/content/7/1/252
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Febrile patients with suspected or confirmed HIV infec-
tion, particularly those, who have neck stiffness or dura-
tion of symptoms longer than two weeks, should be
carefully evaluated for differential diagnoses other than
malaria. The possibility of a double infection with malaria
in addition to another infection must also be considered.
Neither this study, nor a study from Burkina Faso [15]
demonstrated any increased risk of severe malaria infec-
tion or fatal outcome of malaria in HIV positive patients,
but the small sample sizes in both studies may limit the
studies' ability to evaluate that question. However, in
areas with unstable malaria transmission, studies have
shown an association between HIV-status and severity
and lethality of malaria [14,27]. A potential bias in several
of the studies on malaria severity and mortality in HIV
patients may be the pre-selection or inclusion of only
patients with relatively mild malaria infection
[8,10,20,28]. While previous studies on the outcome of
malaria largely used other treatment regimens [9,12,16],
most severe malaria cases in the current study were treated
with the highly efficient artesunate combination therapy,
which may have reduced the case-fatality rates. Since
other studies have indicated that acquired immunity
against malaria is important when there is partial drug-
resistance [29], the use of artesunate combination therapy
may diminish any differences in treatment success
between HIV positive and HIV negative individuals.
The low prevalence of malaria parasitemic patients may
be a result of the increased government eradication effort
in the main patient recruiting area, but may also be a con-
sequence of false negative malaria tests due to intake of
effective or ineffective antimalarials prior to admission, or
inaccurate laboratory diagnosis. Using thick malaria
blood smears only in the malaria diagnosis may result in
an increased number of false negative blood slides [25].
Since malaria in HIV positive patients is known to present
with uncharacteristic clinical features, HIV positive
patients and those with unknown HIV status whom were
not tested for malaria, may represent a potential bias
underestimating the prevalence of malaria. However, the
case-fatality rate in the group with unknown results for
HIV and/or malaria was not significantly different from
those with known results.
Hypoglycaemia was associated with increased risk of fatal
outcome and the only clinical finding associated with a
rejected malaria diagnosis. Hypoglycaemia may be an
adverse effect of quinine treatment, which 11% of the
patients received, or other medicines such as trimetho-
prim-sulfamethoxazole, which 44% received. Alterna-
tively, the hypoglycaemia may be due to malnutrition,
other super-infection, a double infection with both
malaria and another infection, or an independent indica-
tor of severe disease [30].
Potential biases of the study include possible underreport-
ing of the HIV and malaria, since malaria and/or HIV test
was not performed for 92 patients. Particularly, since HIV-
patients may present with atypical signs and symptoms of
malaria [1,14], there is a possibility that HIV infected
study subjects, with known or unknown HIV status, may
have suffered from undiagnosed malaria. Patients with
low or no incomes may be underrepresented due to the
admission fee of approximately 6 USD for those who do
not have a referral letter, while wealthy patients may be
underrepresented because they tend to prefer private
health care. This may represent a bias, since lower socio-
economical status is associated with poorer housing and
lower use of impregnated bed nets, and hence higher fre-
quency of malaria [31]. Furthermore, relatively healthy
patients were treated as outpatients and not admitted
while some severely ill patients were transferred to the
intensive care unit. The severity of disease in this cohort
reflects that patients, screening nurses at the primary
health care level and doctors in the Emergency Unit have
a high threshold for referring and admitting patients to
the hospital. Among all patients attending the Emergency
Unit with suspected malaria infection during one week,
about half of the patients were discharged directly after
some hours of observation. Patients admitted during
weekends, who either were discharged or died before the
next working day, probably represent the least ill and the
most severely ill patients, respectively, and since there was
less clinical follow-up and laboratory investigation per-
formed during weekends, these patient groups may repre-
sent a selection bias. Finally, pregnancy tests were not
routinely done in this ward, and thus, hidden pregnancies
may represent a bias giving increased severity of the
malaria infection. However, no difference in severity of
malaria between the sexes was observed.
Conclusion
The severity of immunosuppression due to HIV-stage,
hypoglycaemia and hypotension were associated with
fatal outcome in this study. The findings of the study indi-
cate that the fraction of febrile illness attributable to
malaria is less in HIV positive than in HIV negative per-
sons. This finding is plausible since opportunistic and
other infections may mimic malaria in HIV patients. It
raises concern of overuse of antimalarials and missed
treatment opportunities for opportunistic infections in
HIV positive patients. In patients presenting with febrile
illness in areas where both HIV and malaria are endemic,
clinicians must make additional efforts to rule out oppor-
tunistic infections and other differential diagnoses to
malaria. Knowledge of HIV status is valuable in the diag-
nostic evaluation of patients with suspected malaria, andMalaria Journal 2008, 7:252 http://www.malariajournal.com/content/7/1/252
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HIV testing should be considered as part of the early eval-
uation.
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